Elaine Hodges
Family Medicine · Madison, GANPI 1134158124
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 191 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $871 and has fallen 97.6% since, to $21 in 2024.
Across 191 payments — averaging $15.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$486
- Novo Nordisk$347
- AstraZeneca$211
- Amarin Pharma, Inc.$179
- Lilly USA, LLC$174
- Supernus Pharmaceuticals, Inc.$155
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,977100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 37 | $486 |
| Novo Nordisk | 29 | $347 |
| AstraZeneca | 13 | $211 |
| Amarin Pharma, Inc. | 11 | $179 |
| Lilly USA, LLC | 11 | $174 |
| Supernus Pharmaceuticals, Inc. | 5 | $155 |
| Pfizer | 9 | $154 |
| Amgen | 9 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $130 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $121 |
| GSK | 6 | $101 |
| Boehringer Ingelheim | 4 | $87 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $76 |
| Bayer | 5 | $76 |
| Astellas Pharma US Inc | 3 | $63 |
| Biohaven Pharmaceuticals, Inc. | 3 | $58 |
| Sanofi-aventis U.S. LLC | 3 | $51 |
| Esperion Therapeutics, Inc. | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| Genentech USA, Inc. | 2 | $35 |
| Kaleo, Inc. | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Scynexis, Inc. | 1 | $19 |
| Optinose US, Inc. | 1 | $19 |
| Novartis | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Eisai Inc. | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $12 |
| Hikma Pharmaceuticals USA | 1 | $12 |
| Dexcom, Inc. | 1 | $11 |
| Merck | 1 | $11 |
How this compares
$2,977 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Madison
- Jeffrey KingsleyColumbus$404K
- Debbie HaginsSavannah$279K
- Yolanda WadeTyrone$233K
- Julian HutchinsWarrenton$222K
- Nadine Halliburton-FosterCumming$219K
- Contessa MetcalfeAtlanta$157K
- Elmore AlexanderStone Mountain$155K
- Bantwal BaligaColumbus$115K
- Avril CampbellFort Benning$108K
- Mitzi RubinMarietta$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.